- Home
- Products
- Customized FluoroAb™
- GUCY2C
- Anti-GUCY2C MAb (Clone 1)-iFluor® 532 Succinimidyl Ester
Anti-GUCY2C MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12646)
- TARGET
- ANTIBODY
- DYE
- Name
- GUCY2C
- Alternative Names
- GUCY2C; DIAR6; GUC2C; MECIL; MUCIL; STAR; guanylate cyclase 2C; GC-C
- Overview
- Anti-GUCY2C antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 532 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 537/560
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS12646. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-210 | Anti-GUCY2C-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-209 | Anti-GUCY2C-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-403 | Anti-GUCY2C-MMAE ADC | Cleavable peptide linker | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CCR5 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS161)
- Moxetumomab pasudotox-iFluor 405 (CAT#: ADC-FL-452)
- Anti-CD2 MAb (Clone 7)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14946)
- Anti-NGF MAb (Clone 7)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10664)
- Anti-APP MAb (Clone 18)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1084)
- Teneliximab-iFluor 594 (CAT#: ADC-FL-746)
- Anti-CMV MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9951)
- Anti-S1P MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13103)
- Anti-SELL MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4560)
- Anti-CD80 MAb (Clone 4)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16602)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
